Cellectis S.A. current report, Q3 FY2022

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on September 28, 2022. The filing serves to incorporate a press release dated September 28, 2022, by reference into the company's existing registration statements (Form F-3 and Form S-8).

Key Financial Metrics

The provided filing text contains only cover page and signature information. It does not include the content of the referenced press release or any financial statements. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not available in this document.

Material Changes

No material changes regarding financial performance or operations are detailed in the text of this Form 6-K. The filing acts solely as a vehicle to distribute the attached press release (Exhibit 99.1), the content of which is not included in the source text.

Guidance, Outlook, and Risks

The filing text does not provide management commentary, future guidance, risk factors, or details on contingencies. These elements would be contained within the press release referenced as Exhibit 99.1, which is not present in the input data.

Investor Verification Checklist

  • Verify the content of the press release dated September 28, 2022 (Exhibit 99.1), as the Form 6-K text itself contains no operational or financial data.
  • Confirm the specific announcement made by the company on this date, as the filing only references the existence of the release.
  • Review the company's most recent Form 20-F or quarterly reports for the latest audited financial metrics, as this filing does not provide them.